glp-1 market news Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Market Trends | Whitepaper

Liraglutide injection should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus

For example, North Carolina and West Virginia have recently eliminated coverage of GLP-1s for weight loss for state employees due to cost concerns

15 , 16 Similarly, in animal models of PD, GLP-1 medicines including exenatide, liraglutide, and semaglutide suppress astrocytic and microglial activation, lower pro-inflammatory cytokine levels in the brain, and reduce oxidative stress, while improving motor performance and dopaminergic neuron survival

The GLP-1 Boom of 2026: Why Is Everyone Asking About Cost